Raymond James & Associates’s Hims & Hers Health HIMS Stock Holding History

Raymond James & Associates’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$718K	Sell	38,969 -16,047	-29%	-$287K	﹤0.01%	2892
2024 Q2	$1.11M	Buy	55,016 +41,333	+302%	+$688K	﹤0.01%	2558
2024 Q1	$212K	Buy	+13,683	New	+$154K	﹤0.01%	3585
2023 Q2	–	Sell	-25,420	Closed	-$252K	–	3892
2023 Q1	$252K	Buy	+25,420	New	+$223K	﹤0.01%	3359
2022 Q1	–	Sell	-31,281	Closed	-$205K	–	4181
2021 Q4	$205K	Buy	+31,281	New	+$226K	﹤0.01%	3689

Other funds holding HIMS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IVMX

Institutional Venture Management XVI Menlo Park, California $1.18M AUM 156.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Raymond James & Associates's HIMS Position: Q3 2024 in Review

Raymond James & Associates reduced its Hims & Hers Health (HIMS) stake by 29% in Q3 2024, selling an estimated $287K and leaving 38,969 shares worth $718K. The position accounts for ﹤0.01% of the portfolio, ranked #2892.

Raymond James & Associates first reported a position in HIMS in Q4 2021 and has held it in 5 quarters since. The position peaked at $1.11M in Q2 2024. 308 funds tracked by Wall St. Rank hold HIMS as of Q3 2024.

Raymond James & Associates held 38,969 shares of Hims & Hers Health worth $718K as of Q3 2024.
Raymond James & Associates sold 16,047 Hims & Hers Health shares in Q3 2024, an estimated $287K.
Hims & Hers Health made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2892 holding.
Raymond James & Associates first reported a position in Hims & Hers Health in Q4 2021 and has held it in 5 quarters since.
Raymond James & Associates's Hims & Hers Health position peaked at $1.11M in Q2 2024.
308 funds tracked by Wall St. Rank held Hims & Hers Health as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.